Activation of c-Jun NH2-terminal kinases by interleukin-1β in normal human oteoblastic and rat UMR-106 cells

Journal of Cellular Biochemistry

Volumn 69, Issue 1, 1998, Pages 87-93

  Chaudhary, Lala R ^a   Avioli, Louis V ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human osteoblasts; Interleukin 1 ; JNK; MAP kinase pathways; UMR 106 cells

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ARTICLE; CELL CULTURE; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C JUN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PROTEIN KINASES; RATS;

ANIMALIA;

EID: 0032054919     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980401)69:1<87::AID-JCB10>3.0.CO;2-C     Document Type: Article

References (32)

1. Ahlers A, Belka C, Gaestel M, Lamping N, Sott C, Herrmann F, Brach MA (1994): Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells. Mol Pharmacol 46:1077-1083.
2. Chaudhary LR, Avioli LV (1996): Regulation of interleukin-8 gene expression by interleukin-1β, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271:16591-16596.
3. Chaudhary LR, Avioli LV (1997a): Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: Differences in mobility and in-gel renaturation of ERK1 in human, rat and mouse osteoblastic cells. Biochem Biophys Res Commun 238:134-139.
4. Chaudhary LR, Avioli LV (1997b): Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: Attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin. Mol Cell Biochem (in press).
5. Chaudhary LR, Cheng S-L, Avioli LV (1996): Induction of early growth response-1 gene by IL-1β and tumor necrosis factor-α in normal human bone marrow stromal and osteoblastic cells. Regulation by a protein kinase C inhibitor. Mol Cell Biochem 156:69-77.
6. Cobb MH, Goldsmith EJ (1995): How MAP kinases are regulated. J Biol Chem 270:14843-14846.
7. Cunningham Jr, ET, De Souza EB (1993): Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 14:171-176.
8. Fujita T, Matsui T, Nakao Y, Shiozawa S, Imai Y (1990): Cytokines and osteoporosis. Ann NY Acad Sci 587:371-375.
9. Gardner AM, Johnson GL (1996): Fibroblast growth factor-2 suppression of tumor necrosis factor-α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271:14560-14566.
10. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG (1983): An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306:378-380.
11. Guesdon F, Freshney N, Waller RJ, Rawlinson L, Saklatvala J (1993): Interleukin 1 and tumor necrosis factor stimulate two novel protein kinases that phosphorylate the heat shock protein hsp27 and β-casein. J Biol Chem 268:4236-4243.
12. Hanazawa S, Ohmori Y, Amano S, Hirose K, Miyoshi T, Kumegawa M, Kitano M (1986): Human purified interleukin-1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3-E1), but enhances alkaline phosphatase activity in the cells. FEBS Lett 203:279-284.
13. Kyriakis JM, Avruch J (1996): Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313-24316.
14. Mendelson KG, Contois L-R, Tevosian SG, Davis RJ, Paulson KE (1996): Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93:12908-12913.
15. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Cobb M, Davis RJ, Johnson GL, Karin M (1994): Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
16. Nagata Y, Nishida E, Todokoro K (1997): Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89:2664-2669.
17. Nguyen L, Dewhirst FE, Hauschka PV, Stanshenko P (1991): Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. J Bone Miner Res 10: 15-21.
18. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, Peck WA (1987): Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 84:4616-4620.
19. Pacifici R, Rifas L, McCracken R, Vered I, McMurray C, Avioli LV, Peck WA (1989): Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
20. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989): Interleukin 1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
21. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ (1995): Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
22. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T (1997): Tumor necrosis factor-α-induced E-selection expression is activated by the nuclear factor-kB and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 272:2753-2761.
23. Scherle PA, Pratta MA, Feeser WS, Tancula EJ, Arner EC (1997): The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes. Biochem Biophys Res Commun 230:573-577.
24. Segar R, Krebs EG (1995): The MAPK signaling cascade. FASEB J 9:726-735.
25. Siddhanti SR, Hartle II JE, Quarles LD (1995): Forskolin inhibits protein kinase C-induced mitogen-activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 136:4834-4841.
26. Stanshenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD (1987): Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565.
27. Su B, Karin M (1996): Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8:402-411.
28. Thomson BM, Saklatvala J, Martin, TJ (1986): Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112.
29. Tsuji M, Funahashi S, Takigawa M, Seikik M, Fujii K, Yoshida T (1996): Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte. FEBS Lett 381:222-226.
30. Verheijen MHG, Defize HK (1995): Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway. Endocrinology 136:3331-3337.
31. Wilmer WA, Tan LC, Dickerson JA, Danne M, Rovin BH (1997): Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells: Role of oxidation. J Biol Chem 272:10877-10881.
32. Zhang W, Dziak RM, Aletta JM (1995): EGF-mediated phosphorylation of extracellular signal-regulated kinases in osteoblastic cells. J Cell Physiol 162:348-358.